Financial results - BIOMEDICA SRL

Financial Summary - Biomedica Srl
Unique identification code: 4206462
Registration number: J1993001068157
Nace: 8622
Sales - Ron
834.250
Net Profit - Ron
62.855
Employees
18
Open Account
Company Biomedica Srl with Fiscal Code 4206462 recorded a turnover of 2024 of 834.250, with a net profit of 62.855 and having an average number of employees of 18. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biomedica Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 453.963 638.657 663.636 720.721 734.655 635.774 838.140 820.256 826.781 834.250
Total Income - EUR 454.737 653.051 665.684 725.705 736.715 653.892 849.788 825.593 833.850 841.924
Total Expenses - EUR 330.551 387.192 485.798 569.478 621.680 700.650 742.114 737.095 734.394 766.599
Gross Profit/Loss - EUR 124.186 265.858 179.886 156.228 115.035 -46.758 107.674 88.498 99.456 75.325
Net Profit/Loss - EUR 110.020 236.141 152.892 148.973 107.645 -52.448 99.565 80.404 89.942 62.855
Employees 14 14 19 19 21 19 20 20 17 18
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.5%, from 826.781 euro in the year 2023, to 834.250 euro in 2024. The Net Profit decreased by -26.584 euro, from 89.942 euro in 2023, to 62.855 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biomedica Srl

Rating financiar

Financial Rating -
BIOMEDICA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biomedica Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biomedica Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biomedica Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biomedica Srl - CUI 4206462

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 164.276 194.275 208.460 263.023 231.365 197.599 142.507 132.964 101.836 123.651
Current Assets 73.185 141.950 141.622 164.956 149.258 137.744 139.135 103.296 150.146 128.196
Inventories 0 33.490 9.204 10.066 0 710 1.792 0 0 1.225
Receivables 30.283 42.497 47.556 43.599 44.601 3.349 9.121 16.613 29.018 17.659
Cash 42.902 65.963 84.862 111.292 104.657 133.685 128.222 86.683 121.128 109.311
Shareholders Funds 217.567 269.690 254.176 250.015 352.841 293.704 215.917 175.811 187.620 159.399
Social Capital 90 89 88 86 84 83 81 81 81 80
Debts 20.848 67.246 96.344 177.965 31.576 41.639 65.725 60.450 64.362 92.448
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 128.196 euro in 2024 which includes Inventories of 1.225 euro, Receivables of 17.659 euro and cash availability of 109.311 euro.
The company's Equity was valued at 159.399 euro, while total Liabilities amounted to 92.448 euro. Equity decreased by -27.172 euro, from 187.620 euro in 2023, to 159.399 in 2024.

Risk Reports Prices

Reviews - Biomedica Srl

Comments - Biomedica Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.